Antibodies to mannose binding lectin in patients with systemic lupus erythematosus

Lupus

Volumn 13, Issue 7, 2004, Pages 522-528

  Mok, M Y ^a,d   Jack, D L ^b,e   Lau, C S ^c   Fong, D Y T ^c   Turner, M W ^b   Isenberg, D A ^a   Lydyard, P M ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d QUEEN MARY HOSPITAL   (Hong Kong)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Anti MBL antibodies; ELISA; Immune complex; MBL deficiency

Indexed keywords

ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MANNOSE BINDING LECTIN;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNOLOGY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MANNOSE-BINDING LECTINS; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 4043056414     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu1055oa     Document Type: Article

References (49)

1. Sim RB, Reid KBM. C1: molecular interactions with activating systems. Immunol Today 1991; 9: 307-311.
2. Lau YL, Lau CS, Chan SY, Karlberg J, Turner MW. Mannose-binding protein in Chinese patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39: 706-708.
3. Ip WK, Chan SY, Lau CS, Lau YL. Association of systemic lupus erythematosus with promoter polymorphism of the mannose-binding lectin gene. Arthritis Rheum 1998; 41: 1663-1668.
4. Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum 1996; 39: 2046-2051.
5. Davies EJ, Snowden N, Hillarby MC et al. Mannose-binding protein gene polymorphism in systemic lupus erythematosus. Arthritis Rheum 1995; 38: 110-114.
6. Davies EJ, Teh LS, Ordi-Ros J et al. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population. J Rheumatol 1997;24:485-488.
7. Sastry K, Ezekowitz RA. Collectins: pattern recognition molecules involved in first line host defense. Curr Opin Immunol 1993; 5: 59-66.
8. Thiel S, Holmskov U, Hviid L, Laursen SB, Jensenius JC. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol 1992; 90: 31-35.
9. Turner MW. Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 1996; 17: 532-540.
10. Taylor ME, Brickell PM, Craig RK, Summerfield JA. Structure and evolutionary origin of the gene encoding a human serum mannose-binding protein. Biochem J 1989; 262: 763-771.
11. Lipscombe RJ, Sumiya M, Summerfield JA, Turner MW. Distinct physicochemical characteristics of human mannose binding protein expressed by individuals of differing genotype. Immunology 1995; 85: 660-667.
12. Pistole TG. Interaction of bacteria and fungi with lectins and lectin-like substances. Ann Rev Microbiol 1981; 35: 85-112.
13. Sutherland IW. Biosynthesis and composition of gram-negative bacterial extracellular and cell wall polysaccharides. Ann Rev Microbiol 1985; 39: 243-270.
14. Polotsky VY, Belisle JT, Mikusova K, Ezekowitz RA, Joiner KA. Interaction of human mannose-binding protein with mycobacterium avium. J Infect Dis 1997; 175: 1159-1168.
15. Hunter SW, Gaylord H, Brennan P. Structure and antigenicity of the phosphorylated lipopolysaccharide antigen from the leprosy and tubercle bacilli. J Biol Chem 1986; 261: 12345-12351.
16. White MR, Crouch E, Chang D, Harshorn KL. Increased anti-viral and opsonic activity of a highly multimeric collectin chimera. Biochem Biophys Res Commun 2001; 286: 206-213.
17. Haurum JS, Thiel S, Jones IM, Fisher PB, Laursen SB, Jensenius JC. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 1993; 7: 1307-1313.
18. Ogden CA, de Cathelineau A, Hoffmann PR et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194: 781-795.
19. Garred P, Madsen HO, Hofmann B, Svejggaard A. Increased frequency of homozygosity of abnormal mannan-binding protein alleles immunodeficiency. Lancet 1995; 346: 941-943.
20. Sumiya M, Super M, Tabona P et al. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991; 337: 1569-1570.
21. Koch A, Melbye M, Sorensen P et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 2001; 10: 1316-1321.
22. Lau YL, Chan SY, Turner MW, Fong J, Karlberg J. Mannose-binding protein in preterm infants: developmental profile and clinical significance. Clin Exp Immunol 1995; 102: 649-654.
23. Summerfield JA, Ryder S, Sumiya M et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995; 345: 886-889.
24. Ip WK, Lau YL, Chan SY et al. Mannose-binding lectin and rheumatoid arthritis in southern Chinese. Arthritis Rheum 2000; 43: 1679-1687.
25. Gradual NA, Madsen HO, Tarp U HK et al. The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2000; 43: 515-521.
26. Garred P, Madwen HO, Marquart H et al. Two edged role of mannose binding lectin in rheumatoid arthritis: a cross sectional study. J Rheumatol 2000; 27: 26-34.
27. Graudal NA, Homann C, Madsen HO et al. Mannan binding lectin in rheumatoid arthritis. A longitudinal study. J Rheumatol 1998; 25: 629-635.
28. Madsen HO, Satz ML, Hogh B, Svejgaard A, Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from Southeast Africa and South America. J Immunol 1998; 161: 3169-3175.
29. Madsen HO, Garred P, Kurtzhals JAL, Lamm LU, Ryder LP, Thiel S. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994; 40: 37-44.
30. Lipscombe RJ, Sumiya M, Hill AVS et al. High frequencies in African and non-African populations of independent mutations in the mannose binding protein. Hum Mol Genet 1992; 9: 709-715.
31. Lipscombe RJ, Beatty DW, Ganczakowski M et al. Mutation in the human mannose-binding protein gene: frequencies in several population groups. Eur J Hum Genet 1996; 4: 13-19.
32. Madsen HO, Garred P, Thiel S et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995; 155: 3013-3020.
33. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
34. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropyschiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
35. Hay EM, Bacon PA, Gordon C et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993; 86: 447-458.
36. Neth O, Jack DL, Johnson M, Klein NJ, Turner MW. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin (MBL) with MBL-associated serine protease following binding to Staphyococcus aureus. J Immunol 2002; 169: 4430-4436.
37. Garred P, Thiel S, Madsen HO, Ryder LP, Jensenius JC, Svejgaard A. Gene frequency and partial protein characterization of an allelic variant of mannan-binding protein associated with low serum concentrations. Clin Exp Immunol 1992; 90: 517.
38. Walport MJ, Davies KA, Botto M. C1q and systemic lupus erythematosus. Immunobiology 1998; 199: 265-285.
39. Slingsby JH, Norsworthy P, Pearce G et al. Homozygous hereditary C1q deficiency and systemic lupus erythematosus. A new family and the molecular basis of C1q deficiency in three families. Arthritis Rheum 1996; 39: 663-670.
40. Siegert CE, Daha MR. C1q as an antigen in humoral autoimmune response. Immunobiology 1998; 199: 295-302.
41. Antes U, Heinz HP, Loos M. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system. J Immunol Methods 1987; 102: 149-156.
42. Hogarth MB, Norsworthy PJ, Allen PJ et al. Autoantibodies to the collagenous region of C1q occur in three strains of lupus-prone mice. Clin Exp Immunol 1996; 104: 241-246.
43. Yoshinoya S, Mizoguchi Y, Aotsuka S, Yokohari R, Nishioka K, Miyamoto T. Circulating immune complex levels measured by new ELISA kits utilizing monoclonal anti-C1q and anti-C3d antibodies correlate with clinical activities of SLE but not with those of RA. J Clin Lab Immunol 1992; 38: 161-173.
44. Guannarsson I, Ronneilid J, Huang YJ et al. Association between ongoing anti C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus. Br J Rheumatol 1997; 36: 32-37.
45. Moroni G, Trendelenburg M, Del Papa N et al. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 2001; 37: 490-498.
46. Trendelenburg M, Marfurt J, Gerber I, Tyndall A, Schifferli JA. Lack of occurrence of severe lupus nephritis among anti-C1q autoantibody-negative patients. Arthritis Rheum 1999; 42: 187-188.
47. Coremans IE, Daha MR, van der Voort EA, Muizert Y, Halma C, Breedveld FC. Antibodies against C1q in anti-glomerular basement membrane nephritis. Clin Exp Immunol 1992; 87: 256-260.
48. Coremans IE, Spronk PE, Bootsma H et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 1995; 26: 595-601.
49. Lhotta K, Wurzner R, Konig P. Glomerular deposition of mannose binding lectin in human glomerulonephritis. Nephrol Dial Transplant 1999; 14: 881-886.